PDCD1 and neoplasm: The binding of PD-1 on T cells to PD-L1 expressed on a tumor cell or PD-L2 expressed on an APC leads to TCR downregulation, resulting in lower secretion of TNF-α, IFN-γ, and IL-2 (92).